DCTH today
$21.77+$1.67 (+8.31%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourStrong Bullish
15 minLeaning Bearish
5 minBullish
Daily trend turns down below $0.01
Key levels
Support$6.49
Support$5.42
Latest news & SEC filings
AnalystCCORF keeps Buy rating on Delcath Systems, lifts target to $27
AnalystHC Wainwright keeps Buy rating on Delcath Systems, lifts target to $36
AnalystBTIG keeps Buy rating on Delcath Systems, lifts price target
All DCTH news →About Delcath Systems
Delcath Systems is an interventional oncology company that develops treatments for cancers in the liver. Its main product, the HEPZATO KIT, combines the chemotherapy drug melphalan with a hepatic delivery system and is approved in the United States for adults with uveal melanoma that has spread to the liver. In Europe, the device component is sold separately as CHEMOSAT for delivering melphalan to the liver. The company operates in the United States and Europe, serving cancer patients through interventional radiology procedures.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
DELCATH SYSTEMS, INC. (DCTH)
What Is the Price Target for DCTH?
SEPT Low Target
$25.00
SEPT Mid Target
$28.50
SEPT High Target
$32.00
Analyst Consensus
$28.50
Is DCTH a Buy or Sell Right Now?
Thesis
- •Revenue growing 129.1% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DCTH.
Start Free Trial →Is DCTH Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$22.77
57
Moat Score
NARROW
7/9
Piotroski Score
23.7
Altman Z-Score
What Is Smart Money Doing with DCTH?
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | director | Buy | 3,627 | - | Oct 13, 2026 |
| Rosalind Advisors, Inc. | director | Sale | 27,502 | - | Oct 13, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DCTH Growth Story
Revenue YoY
129.1%
3yr Revenue CAGR
215.3%
EPS Growth YoY
107.53%
FCF Growth YoY
209.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for DCTH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DCTH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:51:04 | $22.39 | 1,000 | $$22K | BUY |
| 21:09:38 | $21.77 | 191,895 | $$4.2M | SELL |
| 21:00:33 | $21.77 | 5,992 | $$130K | BUY |
| 21:00:01 | $21.77 | 2,363 | $$51K | BUY |
| 21:00:01 | $21.77 | 2,421 | $$53K | BUY |
5 dark pool trades shown · $$4.4M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for DCTH
PREVIEWSEPT Investing provides real-time options flow tracking for DCTH, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $15 | Nov 20 | 9 | $$1860 | 3 | SWEEP |
| CALL | $15 | Nov 20 | 9 | $$640 | 1 | SWEEP |
| CALL | $15 | Nov 20 | 9 | $$640 | 1 | SWEEP |
| CALL | $15 | Nov 20 | 9 | $$640 | 1 | SWEEP |
| CALL | $15 | Nov 20 | 9 | $$640 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for DELCATH SYSTEMS, INC. (DCTH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (7 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DCTH — frequently asked questions
What is DCTH stock price today?
DELCATH SYSTEMS, INC. (DCTH) is at $21.77, up 8.31% (+$1.67) at the Nov 11, 2026 close.
Why is DCTH stock moving today?
Latest DCTH news — Nov 11, 2026: CCORF keeps Buy rating on Delcath Systems, lifts target to $27 · Nov 10, 2026: HC Wainwright keeps Buy rating on Delcath Systems, lifts target to $36
Why did DCTH stock move on Nov 9, 2026?
Delcath Systems shares jumped 9.13% to close at $20.27 after the company reported third-quarter results that beat expectations, with earnings of $0.17 per share versus a $(0.09) estimate and revenue of $35.102M against a $26.027M estimate. The company also raised its full-year 2026 sales guidance to $115M-$117M from a prior range of $104M-$108M, well above the $106.507M analyst consensus.
What is the DCTH price target?
The average analyst price target for DCTH is $28.50, ranging from $25 to $32, based on 2 analysts. Latest: BTIG maintains on Nov 9, 2026.
What do analysts rate DCTH?
Analyst ratings for DCTH: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did DCTH beat earnings?
DCTH last reported on Nov 9, 2026: EPS $0.17 vs -$0.09 expected — a beat of 288.9%.
What is DCTH's P/E ratio?
DCTH trades at a P/E of 1910.5 vs a Healthcare average of 17.3.
Does DCTH pay a dividend?
DCTH does not currently pay a dividend.
What are DCTH support and resistance levels?
Support: $6.49, $5.42, $3.62.
What are insiders doing with DCTH?
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
What is the latest news on DCTH?
Nov 11, 2026: CCORF keeps Buy rating on Delcath Systems, lifts target to $27 · Nov 10, 2026: HC Wainwright keeps Buy rating on Delcath Systems, lifts target to $36 · Nov 9, 2026: BTIG keeps Buy rating on Delcath Systems, lifts price target